Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 17 studies | 28% ± 9% | |
| peripheral blood | 15 studies | 27% ± 11% | |
| brain | 14 studies | 28% ± 13% | |
| eye | 9 studies | 28% ± 13% | |
| kidney | 6 studies | 23% ± 4% | |
| intestine | 6 studies | 27% ± 10% | |
| heart | 5 studies | 25% ± 4% | |
| lymph node | 5 studies | 23% ± 2% | |
| breast | 5 studies | 22% ± 7% | |
| bone marrow | 4 studies | 26% ± 8% | |
| liver | 4 studies | 45% ± 15% | |
| adipose | 4 studies | 41% ± 22% | |
| placenta | 3 studies | 26% ± 8% | |
| uterus | 3 studies | 31% ± 17% | |
| prostate | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 8477.15 | 1445 / 1445 | 100% | 35.92 | 183 / 183 |
| intestine | 100% | 9619.87 | 966 / 966 | 100% | 35.14 | 527 / 527 |
| lung | 100% | 10054.75 | 578 / 578 | 100% | 37.34 | 1155 / 1155 |
| ovary | 100% | 10101.07 | 180 / 180 | 100% | 27.69 | 430 / 430 |
| prostate | 100% | 9218.08 | 245 / 245 | 100% | 33.37 | 502 / 502 |
| skin | 100% | 8418.82 | 1809 / 1809 | 100% | 41.38 | 472 / 472 |
| breast | 100% | 9964.02 | 459 / 459 | 100% | 37.38 | 1116 / 1118 |
| bladder | 100% | 9454.48 | 21 / 21 | 100% | 45.20 | 503 / 504 |
| thymus | 100% | 9877.26 | 653 / 653 | 100% | 43.73 | 603 / 605 |
| stomach | 100% | 6396.47 | 359 / 359 | 100% | 31.74 | 285 / 286 |
| uterus | 100% | 10638.51 | 170 / 170 | 100% | 57.66 | 457 / 459 |
| brain | 100% | 4865.00 | 2630 / 2642 | 100% | 38.40 | 705 / 705 |
| kidney | 100% | 6756.17 | 89 / 89 | 99% | 31.33 | 896 / 901 |
| pancreas | 100% | 4227.53 | 328 / 328 | 99% | 38.20 | 176 / 178 |
| adrenal gland | 100% | 6944.38 | 258 / 258 | 99% | 20.82 | 227 / 230 |
| liver | 100% | 6023.23 | 226 / 226 | 98% | 19.79 | 398 / 406 |
| adipose | 100% | 9931.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 7851.79 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 42.19 | 29 / 29 |
| muscle | 100% | 6444.79 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 9722.50 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 45.75 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 31.37 | 1 / 1 |
| heart | 99% | 4704.89 | 851 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 32.68 | 79 / 80 |
| peripheral blood | 99% | 6524.01 | 916 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0032868 | Biological process | response to insulin |
| GO_0048025 | Biological process | negative regulation of mRNA splicing, via spliceosome |
| GO_0008380 | Biological process | RNA splicing |
| GO_0000375 | Biological process | RNA splicing, via transesterification reactions |
| GO_0006397 | Biological process | mRNA processing |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_1990825 | Molecular function | sequence-specific mRNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | SRSF4 |
| Protein name | Serine and arginine rich splicing factor 4 Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4) |
| Synonyms | SRP75 SFRS4 |
| Description | FUNCTION: Plays a role in alternative splice site selection during pre-mRNA splicing. Represses the splicing of MAPT/Tau exon 10. . |
| Accessions | ENST00000691479.1 A0A0D9SEM4 S4R2X6 ENST00000373795.7 ENST00000466448.4 ENST00000605204.1 Q08170 |